impact factor, citescore
logo
 

Letters to the Editor

 

Obinutuzumab in a patient with overlap syndrome of systemic sclerosis and myositis with perimyocarditis and renal crisis


1, 2, 3, 4

 

  1. Department for Internal Medicine II (Haematology, Oncology, Rheumatology and Clinical Immunology), University Hospital Tübingen, Germany. luisa.schneider@med.uni-tuebingen.de
  2. Department for Internal Medicine II (Haematology, Oncology, Rheumatology and Clinical Immunology), University Hospital Tübingen, Germany.
  3. Department for Diagnostic and Interventional Radiology, University Hospital Tübingen, Germany.
  4. Department for Internal Medicine II (Haematology, Oncology, Rheumatology and Clinical Immunology), University Hospital Tübingen, Germany.

CER20084
2026 Vol.44, N°8
PI 1689, PF 1690
Letters to the Editor

Free to view
(click on article PDF icon to read the article)

PMID: 42635154 [PubMed]

Received: 27/04/2026
Accepted : 15/07/2026
In Press: 20/08/2026
Published: 20/08/2026

Rheumatology Article